Skip to main content

Advertisement

SpringerLink
Log in

Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Du F, Wang W, Li M (2020) Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer. Breast Cancer Res Treat https://doi.org/10.1007/s10549-020-05648-9

    Article  PubMed  Google Scholar 

  2. Poggio F, Bruzzone M, Ceppi M (2018) Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis. Ann Oncol 29:1497–1508. https://doi.org/10.1093/annonc/mdy127

    Article  CAS  PubMed  Google Scholar 

  3. Paluch-Shimon S, Cardoso F, Partridge AH (2020) ESO-ESMO 4th international consensus guidelines for Breast Cancer in Young Women (BCY4). Ann Oncol. https://doi.org/10.1016/j.annonc.2020.03.284

    Article  PubMed  Google Scholar 

  4. Lambertini M, Campbell C, Bines J (2019) Adjuvant anti-HER2 therapy, treatment-related amenorrhea, and survival in premenopausal HER2-positive early breast cancer patients. JNCI J Natl Cancer Inst 111:86–94. https://doi.org/10.1093/jnci/djy094

    Article  CAS  PubMed  Google Scholar 

  5. Lambertini M, Goldrat O, Toss A (2017) Fertility and pregnancy issues in BRCA-mutated breast cancer patients. Cancer Treat Rev 59:61–70. https://doi.org/10.1016/j.ctrv.2017.07.001

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, U.O.C Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132, Genova, Italy

    Marta Perachino & Matteo Lambertini

  2. Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy

    Marta Perachino & Matteo Lambertini

  3. Department of Medical Oncology, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy

    Francesca Poggio

Authors
  1. Marta Perachino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesca Poggio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matteo Lambertini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matteo Lambertini.

Ethics declarations

Conflicts of interest

Matteo Lambertini acted as a consultant for Roche and Novartis, and received speaker honoraria from Takeda, Theramex, Roche, Lilly, Novartis and Pfizer outside the submitted work. The other authors declare no conflicts of interest in relation to this article.

Ethical approval

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Perachino, M., Poggio, F. & Lambertini, M. Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer. Breast Cancer Res Treat 183, 239–240 (2020). https://doi.org/10.1007/s10549-020-05767-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-020-05767-3

Search

Navigation